One of the big problems with pancreatic cancer is that its early symptoms are very easy to miss. They often look like signs ...

This discovery opens the door for new kinds of treatments. If doctors could develop drugs that block CD9 or stop cancer cells ...

Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study.

Cases of pancreatic cancer have increased significantly among younger individuals compared with those aged 35 years and older ...

Arvind Trindade, MD, discusses a large database study looking at rising rates of pancreatic and colon cancer in young adults.

Revolution Medicines, Inc. (NASDAQ:RVMD) on Sunday announced new clinical data for zoldonrasib (RMC-9805), a RAS(ON) ...

A new NIH-led study finds rising rates of 14 cancer types in Americans under 50, especially breast, colorectal, kidney, ...

Pasithea shares rise as early Phase 1 data of PAS-004 shows strong pERK inhibition and tumor shrinkage in advanced cancer ...